DIRECTOR AGREEMENTDirector Agreement • October 12th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledOctober 12th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT ("Agreement") is dated as of October 1, 2017, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Michael T. Borenstein, MD, PHD ("Director''). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."
DIRECTOR AGREEMENTDirector Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT (“Agreement”) is dated as of July 24, 2017, between IMMUDYNE, INC., a Delaware corporation (the “Company”), and Justin Schreiber (“Director”). The Company and the Director are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”
DIRECTOR AGREEMENTDirector Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT ("Agreement") is dated as of July 1, 2017, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and John R. Strawn Jr. ("Director"). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."
DIRECTOR AGREEMENTDirector Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT ("Agreement") is dated as of July 1, 2017, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Anthony Bruzzese M.D. ("Director"). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."
DIRECTOR AGREEMENTDirector Agreement • August 14th, 2017 • Immudyne, Inc. • Medicinal chemicals & botanical products • Texas
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis DIRECTOR AGREEMENT (“Agreement”) is dated as of July 24, 2017, between IMMUDYNE, INC., a Delaware corporation (the “Company”), and Stefan Galluppi (“Director”). The Company and the Director are hereinafter sometimes referred to collectively as the “Parties” and individually as a “Party.”
DIRECTOR AGREEMENTDirector Agreement • March 30th, 2015 • Immudyne, Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledMarch 30th, 2015 Company Industry JurisdictionThis DIRECTOR AGREEMENT (“Agreement") is dated as of September 4, 2014, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Joseph V. DiTrolio, M.D. ("Director"). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."
DIRECTOR AGREEMENTDirector Agreement • October 18th, 2012 • Immudyne, Inc. • Texas
Contract Type FiledOctober 18th, 2012 Company JurisdictionThis DIRECTOR AGREEMENT (“Agreement") is dated as of April 20, 2011, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Dominic Agostini ("Director"). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."
DIRECTOR AGREEMENTDirector Agreement • October 18th, 2012 • Immudyne, Inc. • Texas
Contract Type FiledOctober 18th, 2012 Company JurisdictionThis DIRECTOR AGREEMENT (“Agreement") is dated as of April 20, 2011, between IMMUDYNE, INC., a Delaware corporation (the "Company"), and Anthony Bruzzese M.D. ("Director"). The Company and the Director are hereinafter sometimes referred to collectively as the "Parties" and individually as a "Party."